Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.

Suppr

超能文献

作者信息

Leport C, Puget S, Pepin J M, Levy S, Perronne C, Brun-Vezinet F, Vildé J L

出版信息

J Infect Dis. 1993 Nov;168(5):1329-30. doi: 10.1093/infdis/168.5.1329.

DOI:10.1093/infdis/168.5.1329

PMID:8228376

Abstract

摘要

相似文献

Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.

J Infect Dis. 1993 Nov;168(5):1329-30. doi: 10.1093/infdis/168.5.1329.

Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.

Am J Ophthalmol. 1995 May;119(5):587-96. doi: 10.1016/s0002-9394(14)70217-x.

Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.

Ger J Ophthalmol. 1996 Nov;5(6):490-1.

Clinically resistant cytomegalovirus retinitis.

Semin Ophthalmol. 1995 Jun;10(2):142-9. doi: 10.3109/08820539509059990.

Intraocular therapy for cytomegalovirus retinitis.

J Int Assoc Physicians AIDS Care. 1996 May;2(5):25-8.

[Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].

Nippon Ganka Gakkai Zasshi. 1994 Jul;98(7):710-5.

Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.

J Pediatr Ophthalmol Strabismus. 2016 Oct 22;53:e58-e60. doi: 10.3928/01913913-20161003-02.

Report of a case of aggressive cytomegalovirus retinitis in an infant with AIDS.

Int Ophthalmol. 1996;20(6):333-7. doi: 10.1007/BF00176887.

A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.

J Infect Dis. 2000 Dec;182(6):1765-8. doi: 10.1086/317618. Epub 2000 Oct 17.

Ganciclovir resistance: a matter of time and titre.

Lancet. 2000 Aug 19;356(9230):609-10. doi: 10.1016/S0140-6736(00)02597-6.

引用本文的文献

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Antimicrob Agents Chemother. 2000 Mar;44(3):688-92. doi: 10.1128/AAC.44.3.688-692.2000.

Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.

Antimicrob Agents Chemother. 1998 Sep;42(9):2240-4. doi: 10.1128/AAC.42.9.2240.

What clinicians need to know about antiviral drugs and viral resistance.

Infect Dis Clin North Am. 1997 Dec;11(4):945-67. doi: 10.1016/s0891-5520(05)70399-8.

Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate.

Antimicrob Agents Chemother. 1996 Aug;40(8):1964-6. doi: 10.1128/AAC.40.8.1964.

Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice.

Antimicrob Agents Chemother. 1994 Sep;38(9):2165-8. doi: 10.1128/AAC.38.9.2165.

Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.

J Clin Microbiol. 1995 Mar;33(3):738-41. doi: 10.1128/jcm.33.3.738-741.1995.

Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Drugs. 1994 Sep;48(3):455-84. doi: 10.2165/00003495-199448030-00009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验